Question

In: Accounting

Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the...

Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the company for September 2018 through March 2019. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2018 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $19,000,000 at the bank’s prime rate (12.5% at the time). The company will pay no commitment fees. On October 1, borrowed $16 million cash from Second Commercial Bank under the line of credit and issued a five-month promissory note. Interest at the prime rate of 12% was payable at maturity. Management planned to issue 10-year bonds in February to repay the note. Received $3,500 of refundable deposits in December for reusable containers used to transport and store chemical-based products. For the September–December period, sales on account totaled $4,140,000. The state sales tax rate is 3% and the local sales tax rate is 3%. (This is a summary journal entry for the many individual sales transactions for the period.) Recorded the adjusting entry for accrued interest. 2019 In February, issued $12.4 million of 10-year bonds at face value and paid the bank loan on the March 1 due date. Half of the storage containers covered by refundable deposits were returned in March. The remaining containers are expected to be returned during the next six months. Required: 1. Prepare the appropriate journal entries for 2018 and 2019 transactions. 2. Prepare the current and long-term liability sections of the December 31, 2018, balance sheet. Trade accounts payable on that date were $347,000.

Solutions

Expert Solution

Calculation of the rate of sales tax
Total Sales Tax Rate
Sales Tax Rate (State)+Sales tax rate(Local)
3%+3%
$3,500 6%
Sales Tax
Accounts Receivable *Rate of Tax
$4140000*6%
$248,400
Computation of Accounts Receivable
Sales Revenue+Sales Tax Payable
$4140000+$248400
$4,388,400
Computation of Accrued Interest
Interest Accrued
Notes payable *Rate of Interest*Number of Months/12
$16000000*12%*3/12
$480,000
Computation of interest Expense
Interest Expense
Notes Payable *Rate of Interest *Number of Months/12
$16000000*12%*2/12
$320,000
Computation of cash to be piad
Interest Expense +Interest Payable+Notes Payable
$320000+$480000+$16000000
$16,800,000
Computation of the amount of refundable deposits paid
Refundable Deposits paid
Total Refundable Deposits*1/2
$3500/2
$1,750
1 No Journal Entry will be passed for the negotiation of short term LOC.
Journal Entry
2 Date Account Title Dr Amount Cr Amount
1st Oct 2018 Cash $16,000,000
To Note Payable $16,000,000
to record the issunace of Calculation of the rate of sales tax
promissory note Total Sales Tax Rate
Sales Tax Rate (State)+Sales tax rate(Local)
3 Cash $3,500 3%+3%
To Refundable Deposits $3,500 6%
to record the receipt of Sales Tax
refundable deposits Accounts Receivable *Rate of Tax
$4140000*6%
4 Accounts Receivable $4,388,400 $248,400
To Sales Revenue $4,140,000
To Sales Tax Payable $248,400 Computation of Accounts Receivable
to record the sales and sales Sales Revenue+Sales Tax Payable
tax for sep-dec $4140000+$248400
$4,388,400
5 Interest Expense $480,000
To Interest Payable $480,000 Computation of Accrued Interest
to record the interest Interest Accrued
Accrued Notes payable *Rate of Interest*Number of Months/12
$16000000*12%*3/12
6 Cash $12,400,000 $480,000
To Bonds Payable $12,400,000
to record the issue of
bonds
7 1st March 2019 Interest Expense $320,000 Computation of interest Expense
Interest Payable $480,000 Interest Expense
Notes Payable $16,000,000 Notes Payable *Rate of Interest *Number of Months/12
To cash $16,800,000 $16000000*12%*2/12
to record the repayment $320,000
of bank loan along with Computation of cash to be piad
interest Interest Expense +Interest Payable+Notes Payable
$320000+$480000+$16000000
Refundable Deposits $1,750 $16,800,000
To Cash $1,750
To record the payment of
Refundable Deposits Computation of the amount of refundable deposits paid
Refundable Deposits paid
Total Refundable Deposits*1/2
$3500/2
$1,750
2 Balance Sheet as at 31st Dec 2018
Liabilities Amount
Long Term Liabilities
`
Current Liabilities
a Loan from Second Commercial Bank $16,000,000
c Security Deposits $3,500
d Sales Tax Payable $248,400
e Accrued Interest on loan payable $480,000
f Trade Accounts Payable $347,000
$17,078,900

Related Solutions

Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the...
Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the company for September 2018 through March 2019. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2018 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $15,000,000 at the bank's prime rate (10.5% at the time). The company will pay no commitment fees. On October 1, borrowed $12...
Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the...
Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the company for September 2018 through March 2019. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2018 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $23,000,000 at the bank’s prime rate (9.5% at the time). The company will pay no commitment fees. On October 1, borrowed $20...
Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the...
Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the company for September 2018 through March 2019. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2018 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $8,000,000 at the bank’s prime rate (9.5% at the time). The company will pay no commitment fees. On October 1, borrowed $5...
Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the...
Camden Biotechnology began operations in September 2018. The following selected transactions relate to liabilities of the company for September 2018 through March 2019. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2018 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $19,000,000 at the bank’s prime rate (12.5% at the time). The company will pay no commitment fees. On October 1, borrowed $16...
Camden Biotechnology began operations in September 2016. The following selected transactions relate to liabilities of the...
Camden Biotechnology began operations in September 2016. The following selected transactions relate to liabilities of the company for September 2016 through March 2017. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2016 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $29,000,000 at the bank’s prime rate (9.5% at the time). The company will pay no commitment fees. b. On October 1,...
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the...
Camden Biotechnology began operations in September 2021. The following selected transactions relate to liabilities of the company for September 2021 through March 2022. Camden’s fiscal year ends on December 31. Its financial statements are issued in April. 2021 On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term line of credit of up to $25,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees. On October 1, borrowed $22...
Grossman Products began operations in 2018. The following selected transactions occurred from September 2018 through March...
Grossman Products began operations in 2018. The following selected transactions occurred from September 2018 through March 2019. Grossman's fiscal year ends on December 31. 2018: (a.) On September 5, Grossman opened a checking account and negotiated a short-term line of credit of up to $10,500,000 at 10% interest. The company is not required to pay any commitment fees. (b.) On October 1, Grossman borrowed $8,500,000 cash and issued a 5-month promissory note with 8% interest payable at maturity. (c.) Grossman...
The following selected transactions relate to liabilities of Interstate Farm Implements for December of 2018. Interstate’s...
The following selected transactions relate to liabilities of Interstate Farm Implements for December of 2018. Interstate’s fiscal year ends on December 31. Required: Prepare the appropriate journal entries for these transactions. 1. On December 15, received $7,500 from Bradley Farms toward the purchase of a $98,000 tractor to be delivered on January 6, 2019. 2. During December, received $25,500 of refundable deposits relating to containers used to transport equipment parts. 3. During December, credit sales totaled $800,000. The state sales...
The following selected transactions relate to contingencies of Eastern Products Inc., which began operations in July...
The following selected transactions relate to contingencies of Eastern Products Inc., which began operations in July 2021. Eastern's fiscal year ends on December 31. Financial statements are published in April 2022. No customer accounts have been shown to be uncollectible as yet, but Eastern estimates that 3% of credit sales will eventually prove uncollectible. Sales were $300 million (all credit) for 2021. Eastern offers a one-year warranty against manufacturer's defects for all its products. Industry experience indicates that warranty costs...
The following selected transactions relate to contingencies of Classical Tool Makers, Inc., which began operations in...
The following selected transactions relate to contingencies of Classical Tool Makers, Inc., which began operations in July 2021. Classical’s fiscal year ends on December 31. Financial statements are issued in April 2022. Classical’s products carry a one-year warranty against manufacturer’s defects. Based on previous experience, warranty costs are expected to approximate 3% of sales. Sales were $2.3 million (all credit) for 2021. Actual warranty expenditures were $20,100 and were recorded as warranty expense when incurred. Although no customer accounts have...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT